Blackford and AIQ Solutions Announce Commercial Partnership to Bring Advanced Clinical Decision Support Tools for Metastatic Cancer to Healthcare Providers
14 nov. 2023 09h00 HE
|
Blackford
Blackford and AIQ Solutions Announce Commercial Partnership to Bring Advanced Clinical Decision Support Tools for Metastatic Cancer to Healthcare Providers
Metastatic Cancer Drug Market Size Worth $68.34Bn, Globally, by 2028 at 4.2% CAGR - Exclusive Report by The Insight Partners
13 avr. 2022 05h19 HE
|
The Insight Partners
New York, April 13, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Metastatic Cancer Drug Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Cancer...
Metastatic Cancer Treatment Market Size To Be Worth USD 111.16 Billion by 2027 | Emergen Research
10 déc. 2020 22h00 HE
|
Emergen Research
Vancouver, British Columbia, Dec. 10, 2020 (GLOBE NEWSWIRE) -- The Global Metastatic Cancer Treatment Market is projected to be worth USD 111.16 Billion by 2027, according to the current analysis by...
Biotheranostics CancerTYPE ID aids in patient selection for immunotherapy
21 sept. 2020 08h00 HE
|
Biotheranostics, Inc.
San Diego, CA, Sept. 21, 2020 (GLOBE NEWSWIRE) -- Biotheranostics announces the publication of a new study evaluating CancerTYPE ID® and its role in identifying subsets of patients with Cancer of...
Biotheranostics Announces Chief Commercial Officer
01 avr. 2020 08h00 HE
|
Biotheranostics, Inc.
San Diego, CA, April 01, 2020 (GLOBE NEWSWIRE) -- On April 1, 2020, company veteran and Vice President of Sales, Matt Sargent, was promoted to the position of Chief Commercial Officer. In this...
Protelica Receives a Notice of Allowance by the USPTO on a Novel Antibody Mimics Library of Over 25 Billion Biomolecules
09 déc. 2013 06h30 HE
|
Protelica, Inc.
HAYWARD, Calif., Dec. 9, 2013 (GLOBE NEWSWIRE) -- Protelica, Inc. a Bay Area-based innovator in the field of protein engineering and evolution, has just received a Notice of Allowance by the United...